Medicare More Than Doubles Payment Rate For COVID Monoclonal Antibody Administration At Home
Executive Summary
Regeneron and Eli Lilly have seen limited uptake for their COVID treatments; CMS payment increase addresses concerns that inadequate reimbursement has hampered use of the monoclonal antibody drugs.